No association between genetic variants in angiogenesis and inflammation pathway genes and breast cancer survival among Chinese women

Cancer Epidemiology

Volumn 37, Issue 5, 2013, Pages 619-624

  Dorjgochoo, Tsogzolmaa ^a   Zheng, Ying ^b   Gao, Yu Tang ^c   Ma, Xiangyu ^a,d   Long, Jirong ^a   Bao, Pingping ^b   Zhang, Ben ^a   Wen, Wanqing ^a   Lu, Wei ^b   Zheng, Wei ^a   Shu, Xiao Ou ^a   Beeghly Fadiel, Alicia ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b SHANGHAI MUNICIPAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c SHANGHAI CANCER INSTITUTE   (China)

^d THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Angiogenesis genes; Breast cancer survival; Chinese women; Genetic variants; Inflammation pathway genes

Indexed keywords

CHEMOKINE RECEPTOR CCR2; FIBROBLAST GROWTH FACTOR RECEPTOR 4; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRILYSIN; RANTES; STROMELYSIN; TAMOXIFEN;

ADULT; ANGIOGENESIS; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FEMALE; GENE LOCUS; GENETIC VARIABILITY; GENOTYPE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL;

ANGIOGENESIS GENES; BREAST CANCER SURVIVAL; CCL2; CCL5; CCR2; CHEMOKINE (C-C MOTIF) LIGAND 2; CHEMOKINE (C-C MOTIF) LIGAND 5; CHEMOKINE (C-C MOTIF) RECEPTOR 2; CHINESE WOMEN; COL18A1; COLLAGEN, TYPE XVIII, ALPHA 1; DEOXYRIBONUCLEIC ACID; DFS; DISEASE-FREE SURVIVAL; DNA; ER; ESTROGEN RECEPTOR; FGFR4; FIBROBLAST GROWTH FACTOR RECEPTOR 4; FLT1; FMS-RELATED TYROSINE KINASE 1; GENETIC VARIANTS; HER2; HIF1A; HPGD; HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2; HYDROXYPROSTAGLANDIN DEHYDROGENASE; HYPOXIA INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IL10; IL1B; IL6; INFLAMMATION PATHWAY GENES; INTERLEUKIN 1, BETA; INTERLEUKIN 10; INTERLEUKIN 6; KB; KDR; KILOBASE; KINASE INSERT DOMAIN RECEPTOR; MAF; MATRIX METALLOPEPTIDASE 1; MATRIX METALLOPEPTIDASE 13; MATRIX METALLOPEPTIDASE 2; MATRIX METALLOPEPTIDASE 3; MATRIX METALLOPEPTIDASE 7; MATRIX METALLOPEPTIDASE 9; MINOR ALLELE FREQUENCY; MMP1; MMP13; MMP2; MMP3; MMP7; MMP9; OS; OVERALL SURVIVAL; PERIOSTIN, OSTEOBLAST SPECIFIC FACTOR; PLASMINOGEN ACTIVATOR, UROKINASE; PLAU; POSTN; PR; PROGESTERONE RECEPTOR; PROSTAGLANDIN E SYNTHASE; PROSTAGLANDIN I2 SYNTHASE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 2; PTGES; PTGIS; PTGS2; SBCS; SBCSS; SERPIN PEPTIDASE INHIBITOR, CLADE E, MEMBER 1 (PREVIOUSLY KNOWN AS PAI1); SERPINE1; SHANGHAI BREAST CANCER STUDY; SHANGHAI BREAST CANCER SURVIVAL STUDY; SHANGHAI WOMEN'S HEALTH STUDY; SWHS; TGFB1; THBS1; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR, BETA 1; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VEGFA;

BREAST NEOPLASMS; CHINA; FEMALE; GENETIC VARIATION; GENOTYPE; HUMANS; INFLAMMATION; INFLAMMATORY BREAST NEOPLASMS; MIDDLE AGED; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84884147847     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2013.06.005     Document Type: Article

References (14)

1. Bertos N.R., Park M. Breast cancer - one term, many entities?. J Clin Invest 2011, 121(10):3789-3796.
2. Miller K.D., Dul C.L. Breast cancer: the role of angiogenesis and antiangiogenic therapy. Hematol Oncol Clin North Am 2004, 18(5):1071-1086. ix.
3. DeNardo D.G., Coussens L.M. Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression. Breast Cancer Res 2007, 9(4):212.
4. Smith K.C., Bateman A.C., Fussell H.M., Howell W.M. Cytokine gene polymorphisms and breast cancer susceptibility and prognosis. Eur J Immunogenet 2004, 31(4):167-173.
5. Maae E., Andersen R.F., Steffensen K.D., Jakobsen E.H., Brandslund L., Sørensen F.B., et al. Prognostic impact of VEGFA germline polymorphisms in patients with HER2-positive primary breast cancer. Anticancer Res 2012, 32(9):3619-3627.
6. Gerger A., Renner W., Langsenlehner T., Hofmann G., Knechtel G., Szkandera J., et al. Association of interleukin-10 gene variation with breast cancer prognosis. Breast Cancer Res Treat 2010, 119(3):701-705.
7. Lei H., Hemminki K., Altieri A., Johansson R., Enquist K., Hallmans G., et al. Promoter polymorphisms in matrix metalloproteinases and their inhibitors: few associations with breast cancer susceptibility and progression. Breast Cancer Res Treat 2007, 103(1):61-69.
8. Lei H., Hemminki K., Johansson R., Altieri A., Enquist K., Henriksson R., et al. PAI-1-675 4G/5G polymorphism as a prognostic biomarker in breast cancer. Breast Cancer Res Treat 2008, 109(1):165-175.
9. Forsti A., Jin Q., Altieri A., Johansson R., Wagner K., Enquist K., et al. Polymorphisms in the KDR and POSTN genes: association with breast cancer susceptibility and prognosis. Breast Cancer Res Treat 2007, 101(1):83-93.
10. Zheng W., Long J., Gao Y.T., Li C., Zheng Y., Xiang Y.B., et al. Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nat Genet 2009, 41(3):324-328.
11. Shu X.O., Zheng Y., Cai H., Gu K., Chen Z., Zheng W., et al. Soy food intake and breast cancer survival. JAMA 2009, 302(22):2437-2443.
12. Zheng W., Chow W.H., Yang G., Jin F., Rothman N., Blair A., et al. The Shanghai Women's Health Study: rationale, study design, and baseline characteristics. Am J Epidemiol 2005, 162(11):1123-1131.
13. Long J., Cai Q., Sung H., Shi J., Zhang B., Choi J.Y., et al. Genome-wide association study in east Asians identifies novel susceptibility loci for breast cancer. PLoS Genet 2012, 8(2):e1002532.
14. Beeghly-Fadiel A., Zheng W., Lu W., et al. Replication study for reported SNP associations with breast cancer survival. J Cancer Res Clin Oncol 2012, 138(Jun (6)):1019-1026.